Abveris Inc., a leading biotechnology company headquartered in the United States, specialises in the development of innovative antibody discovery solutions. Founded in 2012, Abveris has established itself as a key player in the biopharmaceutical industry, particularly in the areas of therapeutic antibody development and protein engineering. With a focus on utilising advanced technologies, Abveris offers unique services that streamline the antibody discovery process, ensuring high specificity and affinity. The company has achieved significant milestones, including collaborations with major pharmaceutical firms, which underscore its strong market position. Abveris continues to drive advancements in antibody therapeutics, making it a trusted partner for organisations seeking cutting-edge solutions in drug development.
We don't have data for Abveris Inc., but we can show you information about their parent organization instead.
View parent company